[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on viral proteins encoded by chimpanzee-derived adenovector (ChAd155-RSV)(GSK3389245A) in RSV-seropositive infants.

What is the purpose of the study?

The study will try to find out if the study vaccine against a germ called RSV (respiratory syncytial virus) is safe and may protect against this disease.

Upstate Institutional Review Board (IRB) Number:

939407

Study/Protocol ID:

204838 (RSV PED-002)

Study Phase:

Phase 1/2

Patient Age Group:

Children

Principal Investigator:

Joseph B Domachowske

Who can I contact for more information?

Name: Lori J Ferguson
Phone: 315-464-6331
Email: ferguslo@upstate.edu

Return to Previous Page || Search Again

Top